Replacement of Arg with Nle and modified D-Phe in the core sequence of MSHs, Ac-His-D-Phe-Arg-Trp-NH2, leads to hMC1R selectivity and pigmentation
- PMID: 29679901
- PMCID: PMC6003700
- DOI: 10.1016/j.ejmech.2018.04.021
Replacement of Arg with Nle and modified D-Phe in the core sequence of MSHs, Ac-His-D-Phe-Arg-Trp-NH2, leads to hMC1R selectivity and pigmentation
Abstract
Melanoma skin cancer is the fastest growing cancer in the US [1]. A great need exists for improved formulations and mechanisms to prevent and protect human skin from cancers and other skin damage caused by sunlight exposure. Current efforts to prevent UV damage to human skin, which in many cases leads to melanoma and other skin cancers. The primordial melanocortin-1 receptor (MC1R) is involved in regulating skin pigmentation and hair color, which is a natural prevention from UV damage. The endogenous melanocortin agonists induce pigmentation and share a core pharmacophore sequence "His-Phe-Arg-Trp", and it was found that substitution of the Phe by D-Phe results in increasing melanocortin receptor potency. To improve the melanocortin 1 receptor (MC1R) selectivity a series of tetra-peptides with the moiety of Ac-Xaa-Yaa-Nle-Trp-NH2, and structural modifications to reduce electrostatic ligand-receptor interactions have been designed and synthesized. It is discovered that the tetrapeptide Ac-His-D-Phe(4-CF3)-Nle-Trp-NH2 resulted in a potent and selective hMC1R agonist at the hMC1R (EC50: 10 nM). Lizard anolis carolinensis pigmentation study shows very high potency in vivo. NMR studies revealed a reversed β turn structure which led to the potency and selectivity towards the hMC1R.
Keywords: Melanocortin peptide; Selectivity; Skin pigmentation; Tetra-peptide; hMC1R; α-MSH.
Published by Elsevier Masson SAS.
Figures




Similar articles
-
Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.J Med Chem. 1997 May 23;40(11):1738-48. doi: 10.1021/jm960845e. J Med Chem. 1997. PMID: 9171884
-
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.J Med Chem. 2002 Dec 19;45(26):5736-44. doi: 10.1021/jm020296e. J Med Chem. 2002. PMID: 12477357
-
Design of MC1R Selective γ-MSH Analogues with Canonical Amino Acids Leads to Potency and Pigmentation.J Med Chem. 2017 Nov 22;60(22):9320-9329. doi: 10.1021/acs.jmedchem.7b01295. Epub 2017 Nov 13. J Med Chem. 2017. PMID: 29094944 Free PMC article.
-
99mTc(CO)3-((S-Pyridin-2-ylmethyl)-Cys)-Nle-Asp-His-d-Phe-Arg-Trp-Gly-Lys-NH2.2013 Jan 28 [updated 2013 Apr 18]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2013 Jan 28 [updated 2013 Apr 18]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 23596643 Free Books & Documents. Review.
-
Melanocortins and cardiovascular regulation.Eur J Pharmacol. 1998 Oct 30;360(1):1-14. doi: 10.1016/s0014-2999(98)00615-3. Eur J Pharmacol. 1998. PMID: 9845266 Review.
Cited by
-
Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).ACS Pharmacol Transl Sci. 2024 Aug 26;7(9):2706-2724. doi: 10.1021/acsptsci.4c00129. eCollection 2024 Sep 13. ACS Pharmacol Transl Sci. 2024. PMID: 39296259
-
A TRP Family Based Signature for Prognosis Prediction in Head and Neck Squamous Cell Carcinoma.J Oncol. 2022 Jan 31;2022:8757656. doi: 10.1155/2022/8757656. eCollection 2022. J Oncol. 2022. PMID: 35140788 Free PMC article.
-
Journey through the spectacular landscape of melanocortin 1 receptor.Pigment Cell Melanoma Res. 2024 Sep;37(5):667-680. doi: 10.1111/pcmr.13180. Epub 2024 Jun 10. Pigment Cell Melanoma Res. 2024. PMID: 38857302 Review.
-
Demonstration of a Common DPhe7 to DNal(2')7 Peptide Ligand Antagonist Switch for Melanocortin-3 and Melanocortin-4 Receptors Identifies the Systematic Mischaracterization of the Pharmacological Properties of Melanocortin Peptides.J Med Chem. 2022 Apr 28;65(8):5990-6000. doi: 10.1021/acs.jmedchem.1c01295. Epub 2022 Apr 11. J Med Chem. 2022. PMID: 35404053 Free PMC article.
-
The melanocortin pathway and energy homeostasis: From discovery to obesity therapy.Mol Metab. 2021 Jun;48:101206. doi: 10.1016/j.molmet.2021.101206. Epub 2021 Mar 6. Mol Metab. 2021. PMID: 33684608 Free PMC article. Review.
References
-
- Engel J, Schlesinger-Raab A, Emeny R, Holzel D, Schubert-Fritschle G. Quality of life in women with localised breast cancer or malignant melanoma 2 years after initial treatment: a comparison. Int J Behav Med. 2014;21:478–486. - PubMed
-
- Giuliani D, Minutoli L, Ottani A, Spaccapelo L, Bitto A, Galantucci M, Altavilla D, Squadrito F, Guarini S. Melanocortins as potential therapeutic agents in severe hypoxic conditions. Front Neuroendocrinol. 2012;33:179–193. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information